Director sold ~$172K of Roivant Sciences
Scheduled in advanceLoading…
Insider tradesView the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership
Insider trade
Director sold ~$3.85M of ROIV shares in the open market
Traded Aug 18, 2026 · Filed Aug 19, 2026
- ~$3.85M
- Reported value · 105K sh @ $36.59
- 18.6M
- Holds after · shares reported
- −4.3%
- stock since the trade · S&P 500 +1.0%, $37.37 → $35.78 on Oct 5
Why it stands out
A board member of Roivant Sciences sold $3.85M of Roivant Sciences shares. Nobody planned it ahead of time.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
All the details
Dates, kept separate
- Transaction date
- Aug 18, 2026
- Reporting period
- Not applicable
- Filed with the SEC
- Aug 19, 2026
Director$1M+
Context
- Classification
open market sale
Code S — open-market or private sale
- Absolute commitment
~$3,847,109
Shares × reported transaction price
- Timing vs results
12 days after results of Aug 6, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
- Planned / mechanical clue